Delivery Order SPE2DB22D3102-SPE2DB25FL2VJ
- Not listed
- The Defense Logistics Agency awarded a $2,838.39 delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Clindamycin-Benzoyl Peroxide 1-5% in 50-gram units. This is a firm fixed-price, competitively awarded contract with an ultimate completion date of August 20, 2025, and represents a child order under a larger indefinite delivery contract. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no...
- The Defense Logistics Agency awarded a $2,124.67 delivery order to AmerisourceBergen Drug Corp for clindamycin with benzoyl peroxide 1.2-5% topical solution (45 grams) under a firm fixed price contract. This non-competitive delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a routine pharmaceutical procurement fulfilling military and federal healthcare supply requirements. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Clindamycin Phosphate 1% Lotion in 60ml quantities, with a ceiling value of $3,766.03. This competitive award, issued with firm fixed pricing and no set-aside designation, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Clindamycin 600 mg/50 ml in D5W solution with a ceiling value of $1,210.80 and an ultimate completion date of September 4, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a $1,022.37 firm fixed price delivery order to AmerisourceBergen Drug Corp for Clindamycin Phosphate 1% Gel in 30-gram units, with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded contract with performance to be completed in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a continuation of AmerisourceBergen's ongoing pharmaceutical supply support...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Clindamycin PH 900 mg/6 ml vials with a ceiling value of $17,867.22. This firm fixed-price delivery order, which is not set-aside, will be performed at the vendor's Corporate Office in Conshohocken, Pennsylvania, with an ultimate completion date of July 23, 2025. The contract represents a routine pharmaceutical procurement under the defense medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,561.45 to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Clindamycin 900 mg/50 mL in 5% dextrose solution (50 mL units). This firm fixed price, competitively awarded delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,448.80 to AmerisourceBergen Drug Corp for the supply of Clindamycin PH 1% Solution in 60ml quantities. This contract, awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was...
- The Defense Logistics Agency awarded a delivery order valued at $1,594.49 to AmerisourceBergen Drug Corp for the supply of Clindamycin Phosphate 1% Lotion in 60ml quantities. This competitively awarded, firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of August 20, 2025. The contract carries no set-aside designation, reflecting open competition among qualified pharmaceutical vendors. AmerisourceBergen's Corporate Office in Conshohocken, Pennsylvania...
- The Defense Logistics Agency awarded a $5,047.91 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Clindamycin Phosphate 1% Lotion (60 mL) under a firm fixed-price contract. This delivery order, which is not subject to any set-aside designation, is scheduled for completion by July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2VJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Clindamycin-Benzoyl Peroxide 1-5% in 50-gram units. This $1,220.40 firm fixed-price delivery order is classified as a child contract and represents a non-competitive set-aside award. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The company's contract awards demonstrate its capability to meet federal procurement requirements and serve customers including the Defense Health Agency and U.S. Coast Guard through flexible and comprehensive contract mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/4/25 |